Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain
Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain
Ian Gilron 1, MSc, MD; Dongsheng Tu 2, PhD; Ronald Holden 2, PhD; Tanveer Towheed 2, MD; Elizabeth Vandenkerkhof 2, DrPH; Roumen Milev 2, MD, PhD 1 Queen's University, Department of Anesthesiology and Perioperative Medicine, Queen's University, Kingston, ON,
CA
2 Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute , Kingston, ON,
CA
Corresponding Author:
-
Ian Gilron, MSc, MD
-
Queen's University
-
Department of Anesthesiology and Perioperative Medicine
-
Queen's University
-
Kingston General Hospital
-
76 Stuart Street, Victory 2 Pavillion
-
Kingston, ON
-
CA
-
Phone:
1 613 549 6666 ext 3963
-
Email: gilroni@queensu.ca